Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 164-172

  Chew, Shan Hwu ^a   Okazaki, Yasumasa ^a   Nagai, Hirotaka ^a,b   Misawa, Nobuaki ^a   Akatsuka, Shinya ^a   Yamashita, Kyoko ^a   Jiang, Li ^a   Yamashita, Yoriko ^a   Noguchi, Michio ^b   Hosoda, Kiminori ^b   Sekido, Yoshitaka ^c   Takahashi, Takashi ^a   Toyokuni, Shinya ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AMOSITE; ASBESTOS FIBER; CHRYSOTILE; CROCIDOLITE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DEATH; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDIDYMIS FAT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MACROPHAGE MIGRATION; MALE; MALIGNANT MESOTHELIOMA; MESOTHELIAL CARCINOGENESIS; MESOTHELIUM CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR PROMOTION; UPREGULATION; WOUND HEALING;

3T3-L1 CELLS; ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; ASBESTOS; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MICE; MICE, INBRED STRAINS;

EID: 84891356983     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt267     Document Type: Article

References (50)

1. Wagner,J.C. et al. (1960) Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br. J. Ind. Med., 17, 260-271.
2. Davies,P. et al. (1974) Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature, 251, 423-425.
3. Hamilton,J.A. (1980) Macrophage stimulation and the inflammatory response to asbestos. Environ. Health Perspect., 34, 69-74.
4. Choe,N. et al. (1997) Pleural macrophage recruitment and activation in asbestos-induced pleural injury. Environ. Health Perspect., 105 (suppl. 5), 1257-1260.
5. Ramos-Nino,M.E. et al. (2002) Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression. Cancer Res., 62, 6065-6069.
6. Swain,W.A. et al. (2004) Activation of p38 MAP kinase by asbestos in rat mesothelial cells is mediated by oxidative stress. Am. J. Physiol. Lung Cell. Mol. Physiol., 286, L859-L865.
7. Yang,H. et al. (2006) TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestosinduced oncogenesis. Proc. Natl Acad. Sci. USA, 103, 10397-10402.
8. Jagadeeswaran,R. et al. (2006) Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Cancer Res., 66, 352-361.
9. Yang,H. et al. (2010) Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc. Natl Acad. Sci. USA, 107, 12611-12616.
10. Whitaker,D. et al. (1984) Cytologic and tissue culture characteristics of asbestos-induced mesothelioma in rats. Acta Cytol., 28, 185-189.
11. Suzuki,Y. et al. (1984) Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity. Environ. Res., 35, 277-292.
12. Toyokuni,S. (2009) Mechanisms of asbestos-induced carcinogenesis. Nagoya J. Med. Sci., 71, 1-10.
13. Bolton,R.E. et al. (1982) Variations in the carcinogenicity of mineral fibres. Ann. Occup. Hyg., 26, 569-582.
14. Carthew,P. et al. (1992) Intrapleural administration of fibres induces mesothelioma in rats in the same relative order of hazard as occurs in man after exposure. Hum. Exp. Toxicol., 11, 530-534.
15. Fantuzzi,G. (2005) Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol., 115, 911-9; quiz 920.
16. Greenberg,A.S. et al. (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr., 83, 461S-465S.
17. Itoh,M. et al. (2011) Adipose tissue remodeling as homeostatic inflammation. Int. J. Inflam., 2011, 720926.
18. Bianchini,F. et al. (2002) Overweight, obesity, and cancer risk. Lancet Oncol., 3, 565-574.
19. Calle,E.E. et al. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med., 348, 1625-1638.
20. Reeves,G.K. et al. Million Women Study Collaboration. (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ, 335, 1134.
21. Renehan,A.G. et al. (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 371, 569-578.
22. Hotamisligil,G.S. et al. (1993) Adipose expression of tumor necrosis factoralpha: direct role in obesity-linked insulin resistance. Science, 259, 87-91.
23. Sartipy,P. et al. (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl Acad. Sci. USA, 100, 7265-7270.
24. Kanda,H. et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest., 116, 1494-1505.
25. van Kruijsdijk,R.C. et al. (2009) Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol. Biomarkers Prev., 18, 2569-2578.
26. Cousin,B. et al. (1999) A role for preadipocytes as macrophage-like cells. FASEB J., 13, 305-312.
27. Villena,J.A. et al. (2001) Adipose tissues display differential phagocytic and microbicidal activities depending on their localization. Int. J. Obes. Relat. Metab. Disord., 25, 1275-1280.
28. Usami,N. et al. (2006) Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci., 97, 387-394.
29. Nagai,H. et al. (2011) Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc. Natl Acad. Sci. USA, 108, E1330-E1338.
30. Okby,N.T. et al. (2000) Liposarcoma of the pleural cavity: clinical and pathologic features of 4 cases with a review of the literature. Arch. Pathol. Lab. Med., 124, 699-703.
31. Shen,W. et al. (2003) Adipose tissue quantification by imaging methods: a proposed classification. Obes. Res., 11, 5-16.
32. Nasreen,N. et al. (2000) MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 278, L591-L598.
33. Fuentes,M.E. et al. (1995) Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J. Immunol., 155, 5769-5776.
34. Gunn,M.D. et al. (1997) Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J. Immunol., 158, 376-383.
35. Lu,B. et al. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med., 187, 601-608.
36. Wei,E.K. et al. (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J. Natl Cancer Inst., 97, 1688-1694.
37. Dal Maso,L. et al. (2004) Circulating adiponectin and endometrial cancer risk. J. Clin. Endocrinol. Metab., 89, 1160-1163.
38. Mantzoros,C. et al. (2004) Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab., 89, 1102-1107.
39. Ishikawa,M. et al. (2005) Plasma adiponectin and gastric cancer. Clin. Cancer Res., 11 (2 Pt 1), 466-472.
40. Goktas,S. et al. (2005) Prostate cancer and adiponectin. Urology, 65, 1168-1172.
41. Ajuwon,K.M. et al. (2005) Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol., 288, R1220-R1225.
42. Wulster-Radcliffe,M.C. et al. (2004) Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun., 316, 924-929.
43. Auwerx,J. et al. (1988) Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis, 8, 68-72.
44. Juhan-Vague,I. et al. (1989) Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients-relationship with plasma insulin. Thromb. Haemost., 61, 370-373.
45. Hauner,H. (2005) Secretory factors from human adipose tissue and their functional role. Proc. Nutr. Soc., 64, 163-169.
46. Welsch,C.W. et al. (1977) Prolactin and murine mammary tumorigenesis: a review. Cancer Res., 37, 951-963.
47. Zinger,M. et al. (2003) Prolactin expression and secretion by human breast glandular and adipose tissue explants. J. Clin. Endocrinol. Metab., 88, 689-696.
48. Hugo,E.R. et al. (2008) Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. J. Clin. Endocrinol. Metab., 93, 4006-4012.
49. Jiang,L. et al. (2012) Iron overload signature in chrysotile-induced malignant mesothelioma. J. Pathol., 228, 366-377.
50. Pass,H.I. et al. (2005) Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N. Engl. J. Med., 353, 1564-1573.